[HTML][HTML] Dimethyl fumarate's effectiveness and safety in psoriasis: a real-life experience during the COVID-19 pandemic
M Esposito, A Campanati, A Giunta, G Calianno… - Dermatology and …, 2022 - Springer
Introduction Dimethyl fumarate (DMF) is approved as oral systemic treatment for moderate-to-
severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at the …
severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at the …
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic.
M Esposito, A Campanati, A Giunta… - Dermatology and …, 2022 - europepmc.org
Methods This multicenter, retrospective study included patients with moderate-to-severe
psoriasis who had received a 48-week DMF treatment during the COVID-19 pandemic …
psoriasis who had received a 48-week DMF treatment during the COVID-19 pandemic …
[HTML][HTML] Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic
M Esposito, A Campanati, A Giunta… - Dermatology and …, 2022 - ncbi.nlm.nih.gov
Methods This multicenter, retrospective study included patients with moderate-to-severe
psoriasis who had received a 48-week DMF treatment during the COVID-19 pandemic …
psoriasis who had received a 48-week DMF treatment during the COVID-19 pandemic …
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic
M Esposito, A Campanati, A Giunta… - DERMATOLOGY …, 2022 - art.torvergata.it
Introduction Dimethyl fumarate (DMF) is approved as oral systemic treatment for moderate-to-
severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at the …
severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at the …
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic.
M Esposito, A Campanati, A Giunta… - Dermatology & …, 2022 - search.ebscohost.com
Introduction: Dimethyl fumarate (DMF) is approved as oral systemic treatment for moderate-
to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at …
to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at …
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic
M Esposito, A Campanati, A Giunta… - DERMATOLOGY AND …, 2022 - iris.univpm.it
Introduction: Dimethyl fumarate (DMF) is approved as oral systemic treatment for moderate-
to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at …
to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at …
[PDF][PDF] Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic
M Esposito, ACA Giunta, GCLBF Diotallevi… - 2022 - scienceopen.com
Introduction: Dimethyl fumarate (DMF) is approved as oral systemic treatment for moderate-
to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at …
to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at …
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic
M Esposito, A Campanati, A Giunta… - Dermatology and …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Dimethyl fumarate (DMF) is approved as oral systemic treatment for moderate-to-
severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at the …
severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at the …
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic.
M Esposito, A Campanati, A Giunta… - Dermatology and …, 2022 - europepmc.org
Methods This multicenter, retrospective study included patients with moderate-to-severe
psoriasis who had received a 48-week DMF treatment during the COVID-19 pandemic …
psoriasis who had received a 48-week DMF treatment during the COVID-19 pandemic …
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic
M Esposito, A Campanati, A Giunta… - DERMATOLOGY AND …, 2022 - iris.univpm.it
Introduction: Dimethyl fumarate (DMF) is approved as oral systemic treatment for moderate-
to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at …
to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at …